AGP Limited Secures 1st Position at BCSR Awards 2023

AGP collaborates with Childlife Foundation on Children’s Day 2023

AGP Launched Peridots – A Thanda Solution to Acidity, Gas and Indigestion

AGP secures 2nd Position at BCR Awards 2022

AGP wins Top Exporter Award at 6th PPMA Summit

AGP sponsors KDSP Carnival 2023

AGP bags big win at GDEIB Awards 2023

AGP continues partnership with IBA

AGP continues collaboration with TCF

AGP joins hands with SKMF

AGP continues partnership with ACF

AGP conducts Allergy Awareness Session At Pak Turk Maarif

Gong-Ringing Ceremony of AGP at PSX

Home > Products > Novafol

Product List

Novafol

Generic:

L-Methylfolate

 

Therapeutic Class:

 
Oth Anti-Anaem – Folic Acid  
 

Composition:

 

Each Novafol tablet contains
L-Methylfolate 400 mcg.

 
 

Description:

 

Novafol (L-methylfolate) which
is structurally analogous to the reduced and active form of folic acid
5-methyltetrahydrofolate (L-Methylfolate), is absorbed directly in the
active form that can immediately diffuses into the blood and is available
for its immediate biological action.

 
 

Indications:

 
Novafol tablets are for the
specific dietary management of impaired metabolic processes in those women
with distinct nutritional requirement for any of the following conditions.

  • High risk recurrent pregnancy loss
  • Impaired folic acid absorption and impaired metabolism
  • Hyperhomocysteinemia during pregnancy
 
 

Dosage:

 
Usual dosage of Novafol Tab is 1
or 2 tablets daily.
For folic acid deficiency:

The typical dose is 250-1000 mcg (micrograms) per day.

For preventing neural tube defects: 
At least 400 mcg of folic acid per day from supplements or fortified food should be taken by women capable of becoming pregnant and continued through the first month of pregnancy. Women with a history of previous pregnancy complicated by such neural tube defects usually take 4 mg per day beginning one month before and continuing for three months after conception

For treating high levels of homocysteine in the blood:

  • 0.5-5 mg (milligrams)/day has been used, although 0.8-1 mg/day is appears to be more effective.
  • In people with end-stage renal disease, high homocysteine levels may be more difficult to treat, and doses of 0.8
  • 15 mg/day have been used. Other dosage plans such as 2.5-5 mg 3 times weekly have also been used. Doses higher than 15 mg daily do not seem to be more effective.
 
 

Presentations:

 
  • 400 mcg Tab 30’s